CVE:NSCI Nanalysis Scientific Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Nanalysis Scientific Corp. Please log in to your account or sign up in order to add this asset to your watchlist. C$0.95 +0.02 (+2.15%) (As of 06/29/2022 02:18 PM ET) Add Compare Share Today's RangeC$0.95▼C$0.9550-Day RangeC$0.86▼C$1.3252-Week RangeC$0.86▼C$1.76Volume44,800 shsAverage Volume95,361 shsMarket CapitalizationC$89.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlinesSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NSCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nanalysis Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address NSCI Stock Forecast (MarketRank)Overall MarketRank™0.83 out of 5 starsAnalyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Nanalysis Scientific. Previous Next 4.1 Community Rank Outperform VotesNanalysis Scientific has received 8 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNanalysis Scientific has received 5 “underperform” votes. (Add your “underperform” vote.)Community SentimentNanalysis Scientific has received 61.54% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Nanalysis Scientific and other stocks. Vote “Outperform” if you believe NSCI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NSCI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNanalysis Scientific does not currently pay a dividend.Dividend GrowthNanalysis Scientific does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nanalysis Scientific insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nanalysis Scientific is -22.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nanalysis Scientific is -22.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNanalysis Scientific has a P/B Ratio of 2.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Nanalysis Scientific (CVE:NSCI)Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance (NMR) spectrometers and magnetic resonance imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It operates through three segments: Nanalysis, RS2D, and Corporate. The company also offers software module packages; manufactures and sells cutting-edge electronics components for precision analytical instruments; and provides monitoring and supporting services for its NMR technologies. It sells its products directly, as well as through a network of distributors worldwide. The company is headquartered in Calgary, Canada.Read More NSCI Stock News HeadlinesJune 25, 2022 | americanbankingnews.comNanalysis Scientific (CVE:NSCI) Reaches New 1-Year Low at $0.92June 25, 2022 | americanbankingnews.comNanalysis Scientific (CVE:NSCI) Hits New 12-Month Low at $0.92June 23, 2022 | finance.yahoo.comNanalysis Announces Results of AGM and Appointment of New DirectorJune 11, 2022 | americanbankingnews.comNanalysis Scientific (CVE:NSCI) Shares Down 3.7% June 6, 2022 | finance.yahoo.comNanalysis Presenting at Upcoming ConferencesMay 31, 2022 | finance.yahoo.comNanalysis Reports First Quarter 2022 ResultsMay 26, 2022 | seekingalpha.comNanalysis Scientific's subsidiary secures $160M service and maintenance contract with CATSAApril 29, 2022 | seekingalpha.comNanalysis Scientific Corp. (NSCIF) CEO Sean Krakiwsky on Q4 2021 Results - Earnings Call TranscriptMarch 17, 2022 | benzinga.comNanalysis Scientific Corp. Announces $4,985,000 Funding Contribution from the Canadian GovernmentFebruary 24, 2022 | finance.yahoo.comNanalysis Recognized as a Top 5 Ranked Company by the TSX Venture 50 for 2021January 22, 2022 | seekingalpha.comNanalysis Scientific files for C$8M share offeringJanuary 20, 2022 | finance.yahoo.comNANALYSIS SCIENTIFIC CORP. ANNOUNCES MARKETED PUBLIC OFFERING OF UP TO C$8 MILLIONJanuary 18, 2022 | seekingalpha.comNanalysis enters into a LOI to acquire Quad SystemsSee More Headlines Industry, Sector and Symbol Stock ExchangeCVE Industry Scientific & Technical Instruments Sub-IndustryN/A SectorComputer and Technology Current SymbolCVE:NSCI CUSIPN/A CIKN/A Webwww.nanalysis.com Phone403-769-9499FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio15.83 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio16.76 Current Ratio2.23 Quick Ratio1.82 Sales & Book Value Annual SalesC$18.32 million Price / Sales4.88 Cash FlowC$0.19 per share Price / Cash Flow4.90 Book ValueC$0.43 per share Price / Book2.24Miscellaneous Outstanding Shares94,062,000Free FloatN/AMarket CapC$89.36 million OptionableNot Optionable BetaN/A Nanalysis Scientific Frequently Asked Questions How has Nanalysis Scientific's stock price performed in 2022? Nanalysis Scientific's stock was trading at C$1.45 at the beginning of 2022. Since then, NSCI stock has decreased by 34.5% and is now trading at C$0.95. View the best growth stocks for 2022 here. Who are Nanalysis Scientific's key executives? Nanalysis Scientific's management team includes the following people: Mr. Martin Andrew Burian CPA, CA, CPA, Corp. Sec. & Chairman (Age 58, Pay $7.5k)Mr. Sean Krakiwsky M.Sc., Founder, CEO, Pres & Director (Age 52, Pay $288k)Mr. Luke Caplette C.A., CPA, Chief Financial Officer (Age 33, Pay $187.22k)Mr. Julien Muller, Chief Technology OfficerDr. Heather Phillips, Director of OperationsMr. Matthew Selinger, Investor Relations Mang.Dr. Matt Zamora, Sales Mang.Dr. Susanne Riegel, Director of Marketing & Product Mang.Dr. Greg McFeetors, Head of ManufacturingMr. Neal Gallagher, Head of Product Devel. Who are some of Nanalysis Scientific's key competitors? Some companies that are related to Nanalysis Scientific include AB Dynamics (ABDP), 78790 (PHO.V) (PHO), Opsens (OPS), Quartix Technologies (QTX), exactEarth (XCT), SDI Group (SDI), BSM Technologies (GPS), Kraken Robotics (PNG), SRT Marine Systems (SRT), Starcom (STAR), Remote Monitored Systems (RMS), MedX Health (MDX), Trakm8 (TRAK), PipeHawk (PIP) and OTAQ (OTAQ). View all of NSCI's competitors. What other stocks do shareholders of Nanalysis Scientific own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nanalysis Scientific investors own include Brookfield Infrastructure Partners (BIP.UN), Big 5 Sporting Goods (BGFV), BlackBerry (BB), Brookfield Asset Management (BAM.A), AstraZeneca (AZN), Ayro (AYRO), (ATE), Digital Turbine (APPS), Alamos Gold (AGI) and Air Canada (AC). What is Nanalysis Scientific's stock symbol? Nanalysis Scientific trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NSCI." How do I buy shares of Nanalysis Scientific? Shares of NSCI and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Nanalysis Scientific's stock price today? One share of NSCI stock can currently be purchased for approximately C$0.95. How much money does Nanalysis Scientific make? Nanalysis Scientific (CVE:NSCI) has a market capitalization of C$89.36 million and generates C$18.32 million in revenue each year. How can I contact Nanalysis Scientific? The official website for Nanalysis Scientific is www.nanalysis.com. The company can be reached via phone at 403-769-9499. This page (CVE:NSCI) was last updated on 6/29/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
